BIOMARIN PHARMACEUTICAL INC: revenue
| Value | {"amount": 1313646000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2e76d459-ec4b-49d4-bcfe-676cfeaa3c75
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-005033Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/revenue/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2e76d459-ec4b-49d4-bcfe-676cfeaa3c75
History
- supersedes {"amount": 1270445000, "concept": "us-gaap:SalesRevenueGoodsNet", "currency": "USD"} (evidence 0001564590-18-003114)